Industry
From U.S. (Toll Free) : +16467917070    |   UK : +442030260021     |    sales@businessmarketinsights.com

Asia Pacific Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others)

Report Code :  TIPRE00028625
No. of Pages :  110
Published Month :  Apr 2022
Category :  Chemicals and Materials
$299 per month

Best Plan
  • All Reports in One Industry
  • All Reports Read Access
  • Subscription Duration : 12 Months
  • Monthly New Reports Added
  • $1200 Yearly Saving

The bioresorbable polymers market in Asia Pacific is expected to grow from US$ 782.77 million in 2021 to US$ 1,697.06 million by 2028; it is estimated to grow at a CAGR of 11.7% from 2021 to 2028.

 

The growing number of road and work-related accidents is one of the key factors contributing to the increased demand for orthopedic surgeries in this region. Road and work-related accidents may cause multiple fractures, joint dislocation, ligament damage, and broken bones at several body parts, requiring orthopedic implants to heal and cure the injuries. Bioresorbable polymer-based implants are being widely used for fracture fixation in orthopedic surgeries. Orthopedic implants such as interference screws, plates, pins, suture anchors, and meniscal repair implants as well as simple fracture fixation implants are the most commonly used resorbable implants for anterior cruciate ligament reconstruction, shoulder surgery, meniscal repair, and fracture care. Once the desired function is served, these implants dissolve in the body by themselves during the healing and nurturing process.

 

The ongoing COVID-19 pandemic is anticipated to cause considerable disruptions in the growth of various industries of Asia Pacific. However, the uncertainty regarding future outbreaks, especially in countries such as India and a few other Asian countries, has altered the status of several industrial sectors. The governments of various Asia Pacific countries have taken possible steps to restrict the spread of SARS-CoV-2. The country-wide lockdown enacted by them directly impacted the growth of various industries due to the subsequent shutdown of manufacturing units and disruptions in the supply chains. In India, there has been a reduction in road accidents during the COVID pandemic. According to the Minister for Road Transport and Highways, there was a 26.48% decrease in road accidents. As a result, there was a low need for tissue engineering operations, which hampered the demand for medical implants, thus hindering the bioresorbable polymer market growth in the country.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Asia Pacific bioresorbable polymers market at a good CAGR during the forecast period.

 

 Asia Pacific Bioresorbable Polymers Market Revenue and Forecast to 2028 (US$ Million)  

                                                                                           


Asia Pacific Bioresorbable Polymers Market Segmentation

 

Asia Pacific Bioresorbable Polymers Market – by Type

  • Polylactic Acid (Pla)
  • Polyglycolic Acid (Pga)
  • Polydioxanone
  • Polycaprolactone(Pcl)
  • Others

Asia Pacific Bioresorbable Polymers Market – by Application

  • Orthopedic Devices
  • Drug Delivery
  • Other Application

Asia Pacific Bioresorbable Polymers Market – by Country

  • Australia
  • China
  • India
  • Japan
  • South Korea
  • Rest of APAC

Asia Pacific Bioresorbable Polymers Market – Companies Mentioned

  • Evonik Industries AG
  • Musashino Chemical Laboratory, Ltd.  
  • Ashland Global Holdings Inc.
  • Poly-Med Incorporated
  • Foster Corporation                                               
  • BMG Incorporated                                                 
  • Huizhou Foryou Medical Devices Co., Ltd.        
  • Polysciences Inc.                                                    
  • Bezwada Biomedical LLC                                        
 
  1. Evonik Industries AG
  2. Musashino Chemical Laboratory, Ltd.  
  3. Ashland Global Holdings Inc.
  4. Poly-Med Incorporated
  5. Foster Corporation                                               
  6. BMG Incorporated                                                
  7. Huizhou Foryou Medical Devices Co., Ltd.        
  8. Polysciences Inc.                                                    
  9. Bezwada Biomedical LLC      
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific bioresorbable polymers market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific bioresorbable polymers market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the bioresorbable polymers market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution